Home Tags OAG 022 – April 2019
OAG 022 – April 2019 Related Content
The battle to save Africa’s most threatened wildlife species even as the continent develops, is the view put forward here by CEO of African Wildlife Foundation, Kaddu Sebunya.
Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.
Christian Naczinsky from the Austrian Ministry of Education, Science and Research explains his stance on the European Research Area (ERA) in Austria.
Anke Hagen, Dr.rer.nat, Dr.tec., Professor at DTU Energy explains why it is important that electricity from renewable sources is stored efficiently and why such capacity is needed in the long-term.
Morry Markowitz, President of the Fuel Cell and Hydrogen Energy Association argues that hydrogen is an energy powerhouse with unlimited potential for a cleaner and self-sustaining world in the future.
Upcoming legislation will turn 2019 into a key year for the European Battery Industry, argues Rene Schroeder, Executive-Director of the Association of European Automotive and Industrial Manufacturers (EUROBAT).
Hilary Stephenson, Managing Director of Sigma explains what can be done to power UK railways forward when it comes to the issue of disabled access.
Minister of Social Affairs and Health in Finland, Pirkko Mattila, explains how The Economy of Wellbeing is a means to taking a holistic approach to tackle future challenges.
Jeffrey Borenstein, of the Brain & Behavior Research Foundation argues that research drives the ability to treat mental illness and why funding innovative neurobiological research is a priority.
Adrian Sanders, Secretary-General of The Parliamentarians for Diabetes Global Network (PDGN) reveals how organising globally, acting locally is a sound approach when it comes to tackling diabetes.
Chris Wakefield, Vice President, European Marketing & Product Development, at GOJO Industries-Europe Ltd explores hand hygiene and how infection prevention measures can be strengthened to help save lives.
Barbara Harpham, Chair of the UK-based Medical Technology Group, explains the role that technology can play in reducing the financial and societal burden of diabetes.
In this interview, Dr Carolyn M. Hutter, PhD, Director, Division of Genome Sciences at the National Human Genome Research Institute (NHGRI) outlines the important role of research when it comes to applying genome technologies to studying disease.
Some of the priorities for the environment, maritime affairs and fisheries in Europe are charted here when it comes to the all-important European Commission policy around these crucial themes.
Mike Thomas, Managing Director of Innopsis details the concept of Zero Trust, strongly supported by the Government Digital Service (GDS), as the way ahead for all the networking requirements of the public sector.
Catherine Woodhead, CEO, Muscular Dystrophy UK explains how lives are being transformed through research when it comes to muscle wasting conditions.
Kent J. McDonald, Content Curator at Agile Alliance lifts the lid on Agile software development and the delivery of digital services.
CGIAR Research Program on Grain Legumes and Dryland Cereals is working on genetic improvement of the important crop cowpea to develop high-yielding varieties with resistance to diseases and pests and to increase its production and consumption, as this article from The International Institute of Tropical Agriculture (IITA) explains.
Frédérique Vidal, Minister of Higher Education, Research and Innovation in The French Government explains her stance on the importance of investing in education, innovation and research.
Darren K Griffin, Professor of Genetics and Alan R Thornhill Professor of Reproductive Genetics at University of Kent, School of Biosciences lift the lid on why investing in basic embryology research must be a priority.